Income Taxes (Tables)

12 Months Ended

Dec. 31, 2022

Summary of Income (Loss) Before Income Taxes

The domestic and foreign components of (loss) income before provision for income taxes were as follows:


	2022		2021		2020
Domestic	$	(193,237)	$	(301)	$	12,837
Foreign	(6,063)		(227)		(740)
Total (loss) income before income taxes	$	(199,300)	$	(528)	$	12,097

Schedule of Provision (Benefit) for Income Taxes

The provision (benefit) for income taxes consisted of the following:


	Year Ended December 31,
	2022		2021		2020
Current (benefit) / provision
Federal	$	2	$	(16)	$	(16)
State	77		112		188
Foreign	2,756		1,666		657
Total current (benefit) / provision	$	2,835	$	1,762	$	829
Deferred (benefit) / provision
Federal	$	1,103	$	(23,020)	$	7
State	(850)		(2,682)		4
Foreign	(1,062)		(2,464)		101
Total deferred (benefit) / provision	$	(809)	$	(28,166)	$	112
Total (benefit) / provision
Federal	$	1,105	$	(23,036)	$	(9)
State	(773)		(2,570)		192
Foreign	1,694		(798)		758
Total (benefit) / provision	$	2,026	$	(26,404)	$	941

Summary of Reconciliation of the U.S. Statutory Income Tax Rate to the Company's Effective Tax Rate

A reconciliation of the U.S. federal statutory income tax rate of 21% for the years ended December 31, 2022, 2021 and 2020 to the Company’s effective tax rate is as follows:


	Year Ended December 31,
	2022		2021		2020
Income tax (benefit) provision at the U.S. federal statutory rate	$	(41,853)	$	(111)	$	2,540
State income taxes	(1,732)		(519)		323
Permanent differences	380		292		(53)
Change in valuation allowance	19,660		(18,572)		(3,720)
Effect of foreign operations	(147)		(825)		325
Stock-based compensation	4,205		(838)		198
Transaction costs	—		1,262		—
Section 162(m)	493		—		—
Derivative and warrant liabilities	(1,940)		(6,612)		—
U.S. GILTI inclusion	139		—		—
Goodwill impairment	21,945		—		—
Effect of change in tax rates	(1,253)		(835)		(253)
Sale of foreign subsidiary	—		—		1,323
Research & development tax credits	—		(501)		(253)
Foreign currency translation & transactions	560		254		144
Prior period adjustments	—		—		230
Other	1,569		601		137
Total provision (benefit) for income taxes	$	2,026	$	(26,404)	$	941

Schedule of Deferred Tax Assets and Deferred Tax Liabilities

Significant components of deferred tax assets and liabilities as of were as follows:


	Year Ended December 31,
	2022		2021
Deferred tax assets
Net operating loss carryforwards	$	99,315	$	93,592
Accruals	2,295		3,503
Stock-based compensation	2,834		6,380
Bad debt	351		241
Deferred rent	—		4,167
Interest expense	5,509		735
Lease liabilities	20,022		—
Section 174 capitalized R&D costs	9,826		—
Capitalized production expenses	2,384		—
Other	99		691
Total deferred tax asset	$	142,635	$	109,309
Valuation allowance	(86,515)		(66,848)
Net deferred tax asset	$	56,120	$	42,461

Deferred tax liabilities
Deferred state income tax	(2,178)		(1,596)
Operating lease, right-of-use asset	(16,078)		—
Depreciation and amortization	(1,529)		(1,905)
Intangible assets	(33,131)		(37,352)
Total deferred tax liability	$	(52,916)	$	(40,853)
Net deferred tax asset (liability)	$	3,204	$	1,608

Schedule of Income Tax Examinations

The earliest years’ tax returns filed by the Company that are still subject to examination by the tax authorities in the major jurisdictions are as follows:


			Years
United States			2018
United Kingdom			2021
Japan			2017
Canada			2018